5112.SH.JN - High Yield Electrospinning System
The submission route named on the official notice.
A team at the School of Clinical Dentistry have developed a novel microfiber-based mucoadhesive oral matrix that can deliver drugs and advanced therapeutics directly to the oral mucosa.
This technology is highly acceptable to patients and has been evaluated for clinical use in human studies.
The team at Sheffield are world leading.
We have reported that such matrices can incorporate and release a range of lipophilic, low molecular mass compounds that rapidly diffuse throughout the mucosa following release and without loss of properties.
Moreover, we have incorporated larger macromolecules such as peptides and proteins and achieved high loading efficiency, rapid release profiles and retention of functional activity.
The patches are prepared using electrospinning, a versatile, voltage-driven manufacturing technique that uses electrostatic forces to draw and stretch polymer solutions or melts into continuous micro- and nanofibers.
Electrospinning offers the production of patches that are flexible, enabling them to conform to wet, curved and dynamic surfaces.
Furthermore, their high surface-to-volume ratio facilitates efficient drug loading/release and sustained mucoadhesive interactions, leading to prolonged tissue residence time.
The team have recently secured a UKRI Engineering Biology Mission Award for the adaptation of the technology for mRNA vaccine delivery.
For this award we require a high yield electrospinning system.
For more information about this opportunity, please visit the eSourcing portal at: https://neupc.delta-esourcing.com/tenders/UK-UK-Sheffield:-Laboratory%2C-optical-and-precision-equipments-%28excl.-glasses%29./F92HGE62C9 To respond to this opportunity, please click here: https://neupc.delta-esourcing.com/respond/F92HGE62C9
What the supplier must deliver
A team at the School of Clinical
A team at the School of Clinical Dentistry have developed a novel microfiber-based mucoadhesive oral matrix that can deliver drugs and advanced therapeutics directly to the oral mucosa.
Derived from the notice text — always confirm against the original documents.
What it takes to bid this
Typical UK bid effort for the value not published — mid-band assumed band — an estimate, not a quote.
Qualify & bid/no-bid ~10% · SQ / PQQ ~20% · Written response ~55% · Review & presentation ~15%
Typical for this category — confirm against the ITT pack
- Show at bidComparable references / case studies
- Hold at bidFinancial standing (accounts, often ~2× contract value turnover)
- Hold at bidInsurance cover (PL / EL, often PI)
- Show at bidSocial value commitments
Hold at bid = pass/fail conditions of participation. Show at bid = scored in the quality response. Plan for delivery = contract obligations from day one.
Make the case to bid
Reveal who to approach at University of Sheffield, and generate a go-to-market strategy from their news, accounts and people.
The full intelligence dossier
Our agent reads University of Sheffield’s accounts, hunts live signals, finds the people who decide — and hands you a bid strategy plus a go-to-market influence plan, including what your team should post this week. You approve every paid step.
Ask me about this tender, the buyer, who wins their work, or whether you should bid.
- OCID
- ocds-h6vhtk-06d1b3
- Stage
- tender · Open
- Source
- Find a Tender
- Buyer ref
- 069629-2026
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Laboratory & Precision Equipment
University of Sheffield’s tender network
Assembling the network…